The advent of high-throughput sequencing,34 combined with methylated DNA immunoprecipitation methods (MeDIP),35,36 holds great promise for generating genome-wide methylation maps for a variety of cell lines and tumour cells and of telling us the methylation state of a particular p53 binding site (or other transcription factors in question). The gene discussed is TP53; the disease is neoplasm.